Finland· FI-REL-REL55780
Xigduo
A metformin and dapagliflozin product containing dapagliflozin propanediol monohydrate + metformin hydrochloride, registered in Finland by Abacus Medicine A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Metformin and dapagliflozin is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BD15 (metformin and dapagliflozin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Metformin and dapagliflozin · ATC A10BD15
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Dapagliflozin propanediol monohydrate + Metformin hydrochloride
- Manufacturer
- Abacus Medicine A/S
- Country
- Finland (FI)
- ATC code
- A10BD15
- ATC class
- Metformin and dapagliflozin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for metformin and dapagliflozin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and dapagliflozin · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and dapagliflozin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1a2adab-9f02-4afc-9e1f-cce786d5b18f GET /v1/drugs/e1a2adab-9f02-4afc-9e1f-cce786d5b18f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "5 mg / 1000 mg",
"atc_label": "metformiini ja dapagliflotsiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/13/900/012",
"fimea_rel_id": "REL55780",
"authorised_at": "2019-11-25"
}See everything about metformin and dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.